overweight
Mar 24, 2025
The Obesity Pandemic: What Can we do About it?
Obesity has become one of the most pressing global health challenges, with its prevalence rising at an alarming rate. The causes of obesity are deeply rooted in modern lifestyles, where high-calorie diets, sedentary habits, and environmental influences create the perfect storm for excessive weight gain. Beyond life...
Read More...
Mar 12, 2024
BeiGene’s BRUKINSA Gets FDA Accelerated Approval; GSK’s Positive Results in DREAMM-8 Phase III; Sandoz’s Denosumab Biosimilars FDA Approved; Terns Pharma’s TERN-701 Receives Orphan Drug Designation; Wegovy® Approved in US for Overweight Cardiovascular Risk; Travere Therapeutics Submits sNDA for FILSPARI IgAN Full Approval
BeiGene Receives FDA Accelerated Approval for BRUKINSA in Relapsed/Refractory Follicular Lymphoma BeiGene, Ltd., has declared that the FDA has provided accelerated approval for BRUKINSA® (zanubrutinib) to be used in treating adult patients with relapsed or refractory (R/R) follicular lymphoma (FL), when used alo...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
